Stock Events

Stock Events

SAB Biotherapeutics (SABS) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.15

-0.78

-0.42

-0.06

Details

Expected EPS

-1.106

Actual EPS

-1.12

Surprise EPS

-0.01

Surprise Percent

+1.27%

Description

SAB Biotherapeutics (SABS) has reported earnings of -1.12 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.